Aker BioMarine ASA (OSL:AKBM)
Norway flag Norway · Delayed Price · Currency is NOK
105.80
+0.20 (0.19%)
May 19, 2026, 12:06 PM CET

Aker BioMarine ASA Company Description

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application.

The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications.

In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials.

The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

Aker BioMarine ASA
CountryNorway
Founded2006
IndustryPackaged Foods
SectorConsumer Staples
Employees258
CEOMatts Johansen

Contact Details

Address:
Oksenøyveien 10
Lysaker
Norway
Phone47 24 13 00 00

Stock Details

Ticker SymbolAKBM
ExchangeOslo Børs
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberNO0010886625
SIC Code0900

Key Executives

NamePosition
Seth FrenchChief Executive Officer of Lang Pharma Nutrition Inc
Simon SewardChief Executive Officer of Human Health Ingredients
Trond Atle SmedsrudChief Executive Officer of Emerging Business
Matts JohansenChief Executive Officer
Katrine Mourud KlavenessChief Financial Officer
Marte DalseggExecutive Vice President of People and Communications
Christopher Robin VinterVice President of IR and Corporate Finance
Lise WigerFinancial Controller
Anniken FærgestadVice President of Finance